[1] CHURPEK M M,SNYDER A,SOKOL S,et al.Investigating the impact of different suspicion of infection criteria on the accuracy of quick sepsis-related organ failure assessment,systemic inflammatory response syndrome,and early warning scores[J].Crit Care Med,2017,45(11):1805-1812.
[2] KAUKONEN K M,BAILEY M,PILCHER D,et al.Systemic inflammatory response syndrome criteria in defining severe sepsis[J].N Engl J Med,2015,372(17):1629-1638.
[3] DAVIES G R,MILLS G M,LAWRENCE M,et al.The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness[J].PLoS One,2014,9(9):e108589.
[4] RHODES A,EVANS L E,ALHAZZANI W,et al.Surviving sepsis campaign:international guidelines for management of sepsis and septic shock:2016[J].Crit Care Med,2017,45(3):486-552.
[5] 单亮,修建荣,李秀,等.脓毒症早期诊断生物标志物的再评价[J].中华危重病急救医学,2015,27(6):538-540.
[6] GARNACHO-MONTERO J,HUICI-MORENO M J,GUTIÉRREZ-PIZARRAYA A,et al.Prognostic and diagnostic value of eosinopenia,C-reactive protein,procalcitonin,and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis[J].Crit Care,2014,18(3):R116.
[7] 李真玉,柴艳芬,胡志东,等.血清降钙素原对脓毒症早期诊断价值及预后意义[J].中国医师进修杂志,2010,33(4):27-30.
[8] KIBE S,ADAMS K,BARLOW G.Diagnostic and prognostic biomarkers of sepsis in critical care[J].J Antimicrob Chemother,2011,66(Suppl 2):33-40.
[9] 俞慧,曾元临,周从阳.presepsin在脓毒症诊断中的研究进展[J].中华危重病急救医学,2017,29(8):756-759.
[10] 苏明环,寿松涛.presepsin对脓毒症患者早期诊断和危险分层的临床价值[D].天津:天津医科大学,2014.
[11] 张志忠,周荣斌.心肌标志物在脓毒症心肌损伤中的临床作用[J].医学综述,2009,15(19):2929-2931.
[12] LEVY M M,FINK M P,MARSHALL J C,et al.2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference[J].Crit Care Med,2003,31(4):1250-1256.
[13] KNAUS W A,DRAPER E A,WAGNER D P,et al.APACHEⅡ:a severity of disease classification system[J].Crit Care Med,1985,13(5):818-829.
[14] 李勋,王俊,孔伟,等.脓毒血症患者血清褪黑素水平检测用于预后评估的临床价值[J].东南大学学报(医学版),2017,36(3):465-468.
[15] 余洁,乔忠祥,周汉明,等.miRNA-150、miRNA-146a在脓毒症患儿血清中的表达及其临床意义[J].医学临床研究,2017,34(3):444-447.
[16] 周世林.血乳酸检测在小儿脓毒症预后评估中的临床价值[J].现代医学,2015,43(2):245-247.
[17] 董宏艳,刘先华,周智勇,等.降钙素原和APACHⅡ评分对老年脓毒症患者病情判断及预后评估的研究[J].实用老年医学,2015,29(6):457-460.
[18] 全锦花,崔岩,张新超.血清可溶性白细胞分化抗原14亚型联合动脉乳酸评估脓毒症预后的价值[J].中国急救医学,2017,37(8):685-689.
[19] 张红玉,王佳,孙晓靖.B型钠尿肽及白细胞介素27在脓毒血症患者中的表达及意义[J].标记免疫分析与临床,2016,23(7):783-786.
[20] LIU B,CHEN Y X,YIN Q,et al.Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department[J].Crit Care,2013,17(5):R244.
[21] SHOZUSHIMA T,TAKAHASHI G,MATSUMOTO N,et al.Usefulness of presepsin(sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome[J].J Infect Chemother,2011,17(6):764-769.
[22] YAEGASHI Y,SHIRAKAWA K,SATO N,et al.Evaluation of a newly identified soluble CD 14 subtype as a marker for sepsis[J].J Infect Chemother,2005,11(5):234-238.
[23] 朱娅丽,纪红,张依,等.肌钙蛋白Ⅰ和B型钠尿肽检测在老年脓毒症患者中的临床应用[J].老年医学与保健,2017,23(3):198-200.
[24] ZHANG X,LIU D,LIU Y N,et al.The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults:a meta-analysis[J].Crit Care,2015,19:323.
[25] 全锦花,杨鲁,张新超.血清presepsin(sCD14-ST)联合NEWS评分评估脓毒症患者预后的价值[J].中华急诊医学杂志,2017,26(8):948-952. |